From GlobeNewswire:

The progressive multifocal leukoencephalopathy treatment market is growing rapidly, with a projected value of $2.15 billion by 2028, driven by factors like the rising prevalence of HIV infection. Research and development efforts are also increasing, with key players like Pfizer and Roche investing in innovative therapies. North America leads in market size, with segments based on treatment, indication, administration route, and end-users. The Business Research Company’s Global Market Report provides detailed insights and analysis on this market.



Read more at GlobeNewswire: Understanding The Growth Potential Of Progressive